Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2003;34:909-912
Published online before print February 27, 2003, doi: 10.1161/01.STR.0000060202.63475.BA
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
34/4/909    most recent
01.STR.0000060202.63475.BAv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ay, H.
Right arrow Articles by Saribas, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ay, H.
Right arrow Articles by Saribas, O.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Heart Disease in Women
*Heart Diseases
*Stroke
Related Collections
Right arrow Thrombosis risk factors
Right arrow Echocardiography
Right arrow Acute Cerebral Infarction
Right arrow Arrhythmias, clinical electrophysiology, drugs
Right arrow Embolic stroke
Right arrow Risk Factors for Stroke

(Stroke. 2003;34:909.)
© 2003 American Heart Association, Inc.


Original Contributions

Hyperhomocysteinemia Is Associated With the Presence of Left Atrial Thrombus in Stroke Patients With Nonvalvular Atrial Fibrillation

Hakan Ay, MD; E. Murat Arsava, MD; S. Lale Tokgözoglu, MD; Necla Özer, MD Okay Saribas, MD

From Departments of Neurology (H.A., E.M.A., O.S.) and Cardiology (L.T., N.O.), Hacettepe University Hospital, Ankara, Turkey.

Correspondence to Hakan Ay, MD, Associate Professor of Neurology, Hacettepe University Hospitals, Department of Neurology, Sihhiye 06100, Ankara, Turkey. E-mail ayhmgh{at}hotmail.com

Background and Purpose— Blood stasis is the fundamental mechanism leading to thrombus formation in the venous system. Homocysteine also poses a significant risk for venous thrombosis through its endothelial toxic and prothrombotic properties. In the present study, we hypothesized that high homocysteine might be associated with thrombus formation in another stasis-related condition, atrial fibrillation.

Methods— Forty-two consecutive patients with ischemic stroke caused by nonvalvular atrial fibrillation and admitted within the first day of symptom onset were included. Total fasting plasma homocysteine, serum folic acid, and vitamin B12 levels were measured. All patients were evaluated by transesophageal echocardiography for the presence of a left atrial (LA) thrombus. Homocysteine and vitamin levels were compared between groups with or without LA thrombus.

Results— Transesophageal echocardiography revealed LA thrombus in 20 patients. Mean homocysteine levels were significantly higher in patients with LA thrombus (20.75 versus 13.34 µmol/L, P<0.001). Multivariate logistic regression analysis showed that the effect of high homocysteine was independent of other clinical or echocardiographic variables known to increase LA thrombus (P=0.017). There was no difference in vitamin B12 levels between groups (P=0.118), whereas the mean folic acid level was significantly lower in patients with LA thrombus (P=0.004).

Conclusions— High plasma homocysteine conveys an independent risk for LA thrombus formation in patients with stroke caused by nonvalvular atrial fibrillation. This finding further supports the thrombogenic role of high homocysteine in conditions associated with blood stasis.


Key Words: atrial fibrillation • homocyst(e)ine • stroke • thrombosis




This article has been cited by other articles:


Home page
StrokeHome page
D. Poli, E. Antonucci, E. Cecchi, R. Marcucci, A. A. Liotta, A. P. Cellai, M. Lenti, G. F. Gensini, R. Abbate, and D. Prisco
Culprit Factors for the Failure of Well-Conducted Warfarin Therapy to Prevent Ischemic Events in Patients With Atrial Fibrillation: The Role of Homocysteine
Stroke, October 1, 2005; 36(10): 2159 - 2163.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. Nadar and G. Y.H. Lip
Homocysteine and the Risk of Stroke and Thromboembolism in Atrial Fibrillation: An Uncertain Role
Stroke, September 1, 2003; 34 (9): e143 - e143.
[Full Text] [PDF]